ATE173934T1 - Peptide, die infektionen mit menschlichem immunschwächevirus hemmen und deren anwendungsweisen - Google Patents

Peptide, die infektionen mit menschlichem immunschwächevirus hemmen und deren anwendungsweisen

Info

Publication number: ATE173934T1
Authority: AT; Austria
Prior art keywords: peptides; applications; virus infections; inhibit human; deficiency virus
Prior art date: 1990-08-22

Application number

AT91915038T

Other languages

English (en)

Inventor

Anders Vahlne

Bo Svennerholm

Lars Rymo

Stig Jeansson

Peter Horal

Original Assignee

Anders Vahlne

Bo Svennerholm

Lars Rymo

Stig Jeansson

Peter Horal

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-08-22

Filing date

1991-08-20

Publication date

1998-12-15

1991-08-20 Application filed by Anders Vahlne, Bo Svennerholm, Lars Rymo, Stig Jeansson, Peter Horal filed Critical Anders Vahlne

1998-12-15 Application granted granted Critical

1998-12-15 Publication of ATE173934T1 publication Critical patent/ATE173934T1/de

Links

102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
241000725303 Human immunodeficiency virus Species 0.000 title 1
208000015181 infectious disease Diseases 0.000 title 1
208000031886 HIV Infections Diseases 0.000 abstract 2
208000037357 HIV infectious disease Diseases 0.000 abstract 2
208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 2
NSVOVKWEKGEOQB-LURJTMIESA-N Gly-Pro-Gly Chemical compound NCC(=O)N1CCC[C@H]1C(=O)NCC(O)=O NSVOVKWEKGEOQB-LURJTMIESA-N 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Animal Behavior & Ethology (AREA)
Virology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Dermatology (AREA)
Oral & Maxillofacial Surgery (AREA)
Transplantation (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT91915038T 1990-08-22 1991-08-20 Peptide, die infektionen mit menschlichem immunschwächevirus hemmen und deren anwendungsweisen ATE173934T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US57108090A	1990-08-22	1990-08-22

Publications (1)

Publication Number	Publication Date
ATE173934T1 true ATE173934T1 (de)	1998-12-15

Family

ID=24282265

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT91915038T ATE173934T1 (de)	1990-08-22	1991-08-20	Peptide, die infektionen mit menschlichem immunschwächevirus hemmen und deren anwendungsweisen

Country Status (17)

Country	Link
EP (1)	EP0545991B1 (de)
JP (1)	JP3115596B2 (de)
KR (1)	KR100220531B1 (de)
AT (1)	ATE173934T1 (de)
AU (1)	AU667290B2 (de)
BR (1)	BR9106772A (de)
CA (1)	CA2088788C (de)
DE (1)	DE69130571T2 (de)
DK (1)	DK0545991T3 (de)
ES (1)	ES2128322T3 (de)
FI (1)	FI930519L (de)
GR (1)	GR3029523T3 (de)
HU (1)	HUT63177A (de)
MC (1)	MC2306A1 (de)
NO (1)	NO930401L (de)
OA (1)	OA10051A (de)
WO (1)	WO1992003147A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101370509A (zh) *	2006-01-13	2009-02-18	安克瑞格公司	化合物连同γ辐射在用于治疗癌症中的应用
FR2925501B1 (fr) *	2007-12-21	2012-12-14	Vincience	Peptide activateur de la synthese des aquaporines et composition cosmetique et/ou pharmaceutique le contenant
FR2925500B1 (fr) *	2007-12-21	2011-05-06	Vincience	Peptide derive d'une proteine de la famille des aquaporines et composition cosmetique et/ou pharmaceutique le contenant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3803117A (en)	1972-03-24	1974-04-09	Abbott Lab	Tetrapeptide
US3781272A (en)	1972-03-24	1973-12-25	Abbott Lab	Tripeptide
EP0245362B1 (de) *	1985-10-24	1994-06-29	Ronald C. Kennedy	Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc
NL8702403A (nl) *	1987-10-09	1989-05-01	Stichting Centr Diergeneeskund	Oligopeptiden en gebruik daarvan voor diagnostische en vaccinatiedoeleinden voor aids en arc.

1991
- 1991-08-20 AT AT91915038T patent/ATE173934T1/de not_active IP Right Cessation
- 1991-08-20 DE DE69130571T patent/DE69130571T2/de not_active Expired - Fee Related
- 1991-08-20 FI FI930519A patent/FI930519L/fi not_active Application Discontinuation
- 1991-08-20 CA CA002088788A patent/CA2088788C/en not_active Expired - Fee Related
- 1991-08-20 BR BR919106772A patent/BR9106772A/pt unknown
- 1991-08-20 MC MC912306D patent/MC2306A1/xx unknown
- 1991-08-20 HU HU93456A patent/HUT63177A/hu unknown
- 1991-08-20 WO PCT/SE1991/000544 patent/WO1992003147A1/en not_active Ceased
- 1991-08-20 KR KR1019930700479A patent/KR100220531B1/ko not_active Expired - Fee Related
- 1991-08-20 EP EP91915038A patent/EP0545991B1/de not_active Expired - Lifetime
- 1991-08-20 ES ES91915038T patent/ES2128322T3/es not_active Expired - Lifetime
- 1991-08-20 AU AU84332/91A patent/AU667290B2/en not_active Ceased
- 1991-08-20 JP JP03514399A patent/JP3115596B2/ja not_active Expired - Fee Related
- 1991-08-20 DK DK91915038T patent/DK0545991T3/da active
1993
- 1993-02-05 NO NO93930401A patent/NO930401L/no unknown
- 1993-02-17 OA OA60343A patent/OA10051A/en unknown
1999
- 1999-03-01 GR GR990400618T patent/GR3029523T3/el unknown

Also Published As

Publication number	Publication date
JPH06504035A (ja)	1994-05-12
GR3029523T3 (en)	1999-06-30
ES2128322T3 (es)	1999-05-16
DE69130571T2 (de)	1999-06-17
OA10051A (en)	1996-10-14
AU8433291A (en)	1992-03-17
WO1992003147A1 (en)	1992-03-05
AU667290B2 (en)	1996-03-21
MC2306A1 (fr)	1993-09-27
NO930401L (no)	1993-02-17
BR9106772A (pt)	1993-07-20
NO930401D0 (no)	1993-02-05
DE69130571D1 (de)	1999-01-14
DK0545991T3 (da)	1999-08-16
KR100220531B1 (ko)	1999-10-01
JP3115596B2 (ja)	2000-12-11
FI930519A7 (fi)	1993-04-21
FI930519L (fi)	1993-04-21
CA2088788C (en)	2003-12-16
HU9300456D0 (en)	1993-05-28
HUT63177A (en)	1993-07-28
FI930519A0 (fi)	1993-02-05
EP0545991B1 (de)	1998-12-02
EP0545991A1 (de)	1993-06-16
CA2088788A1 (en)	1992-02-23

Similar Documents

Publication	Publication Date	Title
ATE264914T1 (de)	2004-05-15	Antivirale proteine, dafür kodierende dna, und deren verwendung
CA2073031A1 (en)	1992-05-28	Anti-cd4 antibody homologs useful in prophylaxis and treatment of aids, arc and hiv infection
IL91843A0 (en)	1990-06-10	Hiv proteins and peptides useful in the diagnosis,prophylaxis aids or therapy of aids
RU94022480A (ru)	1996-07-20	Способ лечения гепатита, композиция, усиливающая ин виво инактивацию вируса гепатита с, препарат для лечения гепатита с
DE69838986D1 (de)	2008-02-21	Polypeptide, deren herstellung und verwendung
ATE88900T1 (de)	1993-05-15	Konjugate von interferon alpha mit immunglobulinen.
EA199901031A1 (ru)	2000-06-26	Производные бензимидазола
ATE179614T1 (de)	1999-05-15	Herpes simplex virus vp16 impfstoffe
MY107843A (en)	1996-06-29	Anti-viral compounds.
ATE64601T1 (de)	1991-07-15	Lymphadenopathie-assoziierte huellenantigene und deren verwendungen.
DE58909850D1 (de)	1999-08-26	Arzneimittel zur behandlung von krebs, aids und viruserkrankungen
CY1106615T1 (el)	2012-01-25	Μεθοδος επιταχυνσης αναρρωσης ενος τραυματος χρησιμοποιωντας συνθετικες ή φυσικες οντοτητες που προσομοιωνουν την αποπτωση
NO912825D0 (no)	1991-07-18	Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
FI944561A7 (fi)	1994-09-30	HIV:tä neutraloivia monoklonaalisia yhdistelmähumaanivasta-aineita HIV -infektion ehkäisemiseksi ja hoitamiseksi
EP0306219A3 (de)	1990-07-04	HIV-Proteine und Peptide zur Verwendung in Diagnose, Prophylaxe und Therapie von AIDS
TR199801289T2 (en)	1998-10-21	Terap�tik bile�ikler.
DE69320469D1 (de)	1998-09-24	Behandlung von herpesvirus infektion
ES2036526T3 (es)	1993-06-01	Composiciones de interferon.
DE69130571D1 (de)	1999-01-14	Peptide, die infektionen mit menschlichem immunschwächevirus hemmen und deren anwendungsweisen
DE69330268D1 (de)	2001-07-05	Hämoregulierende peptide
EP0323157A3 (de)	1990-07-25	Antivirale Verbindungen und Methoden
AU2880595A (en)	1996-01-25	Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
GR3014952T3 (en)	1995-05-31	Use of an immunoglobulin-containing composition in the prophylaxis and therapy of AIDS of human.
ITMI913493A1 (it)	1993-06-27	Dispositivo per la disinfezione o la immunizzazione di zone del corpo umano esposte al contagio, da germi, batteri e virus
NO20012417L (no)	2001-07-16	Regulatoriske og utfoldende peptider av Ezrin

Legal Events

Date	Code	Title
2000-03-15	EEIH	Change in the person of patent owner
2000-07-15	EEIH	Change in the person of patent owner
2000-10-15	UEP	Publication of translation of european patent specification
2005-05-15	REN	Ceased due to non-payment of the annual fee